| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $119.1M | +32.2% |
| SG&A Expense | $32.6M | +24.2% |
| Operating Income | -$19.8M | +81.8% |
| Pre-tax Income | -$13.9M | +87.2% |
| Income Tax | $15.1M | +1002.7% |
| Net Income | -$29.0M | +72.8% |
| EPS (Basic) | -$0.69 | +75.6% |
| EPS (Diluted) | -$0.69 | +75.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $159.5M | -52.3% |
| Short-term Investments | $184.4M | +2379.1% |
| Current Assets | $354.0M | +0.7% |
| Total Assets | $364.1M | -1.3% |
| Current Liabilities | $78.6M | +124.1% |
| Total Liabilities | $84.6M | +5.3% |
| Stockholders' Equity | $279.5M | -3.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $322K | +100.4% |
| Capital Expenditures | $602K | -64.4% |
| Investing Cash Flow | -$175.8M | — |
| Financing Cash Flow | $880K | -99.1% |
| Free Cash Flow | -$280K | +99.7% |